You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretroviral Therapy

Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS, who had at least two medical visits during the measurement year, with at least 90 days between each visit, who are receiving potent antiretroviral therapy, who have a viral load < 200 copies/mL after at least 6 months of potent antiretroviral therapy

Date Reviewed: July 26, 2014

Measure Info

NQF 0407CMS 162NQF Endorsement Removed
Measure Type: 
Process
Measure Steward: 
National Committee for Quality Assurance
Clinical Topic Area: 
HIV

Care Setting: 
Outpatient
Data Source: 
Claims
Electronic Health Data
Electronic Health Records

ACP does not support PQRS 162: “HIV/AIDS: HIV RNA Control After Six Months of Potent Antiretroviral Therapy.” Although RNA control is a desirable outcome of HIV treatment, assessment of it at an arbitrary interval is not necessarily a measure of high quality care. The timing of assessment of clinical outcomes should be determined by patient circumstances and may differ from the interval specified.

As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!